Prof. Xianquan Zhan received his M.D. and Ph.D. training in preventive medicine at West China University of Medical Sciences from 1989-1999. He received his post-doctoral training in oncology and cancer proteomics at Central South University and the University of Tennessee Health Science Center (UTHSC). He worked at UTHSC and the Cleveland Clinic in the USA from 2001 to 2012, and achieved the rank of Associate Professor at UTHSC. In 2012, he moved to Central South University and Shandong First Medical University as a Professor, and Advisors of MS/PhD graduate students and postdoctoral fellows. He is also a Fellow of the Royal Society of Medicine, Fellow of EPMA, European EPMA National Representative, Full member of ASCO, AAAS member, Editor-In-Chief of IJCDT, Associate Editors of EPMA Journal and BMC Genomics, and Guest Editors of Frontiers in Endocrinology and Mass Spectrometry Reviews. He has published 195 articles, 30 book chapters, and 2 US patents in the field of clinical proteomics and biomarkers. He edited 10 academic books, including “Proteoforms – Concept and Applications in Medical Sciences”, “Molecular Network Study of Pituitary Adenomas”, “Ubiquitin-Proteasome Pathway”, “Metabolomics - Methodology and Applications in Medical Sciences and Life Sciences”, “Cell Culture - Advanced Technology and Applications in Medical and Life Sciences”, “Modifications of Biomolecules”, and “Biomolecular Modifications in Endocrine-Related Cancers”. As the Guest editor, He edited 18 special issues in SCI journals such as Mass Spectrometry Reviews (IF=10.946), Frontiers in Endocrinology (IF=6.055), EPMA Journal (IF=8.836), and Oxidative Medicine and Cellular Longevity (IF=7.310). His main research interest focuses on the studies of cancer proteomics and proteoforms, multiomics and biomarkers, and the use of modern omics techniques and systems biology for predictive, preventive, and personalized medicine (PPPM) and precision medicine (PM) in cancer.